Metabolic Syndrome
A cluster of five conditions — central obesity, hypertension, dyslipidaemia, hyperglycaemia, low HDL — that together multiply cardiovascular risk.
Definition
Metabolic syndrome is diagnosed when three of five criteria are met: waist circumference above thresholds, triglycerides ≥150 mg/dL, HDL below sex-specific thresholds, blood pressure ≥130/85, and fasting glucose ≥100 mg/dL. It roughly doubles cardiovascular risk and sharply raises type-2 diabetes risk. GLP-1 receptor agonists, Tesamorelin and MOTS-c each target different axes of the syndrome.
Read More
Visceral FatVisceral Adipose Tissue
Fat stored around internal organs — metabolically active, tied to cardiovascular risk, and the target of Tesamorelin and SCULPT.
BiomarkerHbA1cGlycated Haemoglobin
A blood marker of average glucose over the prior 3 months — the standard metric for diabetes screening and GH-axis protocol safety.
BiomarkerFasting Glucose
Blood glucose measured after an 8-hour fast — the simplest metabolic-safety screen before any GH-axis or GLP-1 protocol.
$149 panel.
A clinician reads it in 24 hours.
Order the Peptide Readiness Panel, draw at a Quest or LabCorp near you, and your clinician sends back a matched protocol with a confidence score.